Price: quote on request. Your total cost is quoted in writing per case.
We reply within one business day
Get my quote

Prostate cancer: US-approved treatments and how Gulf families can access them

A plain guide for families in the Gulf, checked against US FDA labels, Gulf drug registers and published medical research.

Reviewed by the Reserve Meds clinical operations team on 17 October 2026.

Prostate cancer: the short answer

The US FDA has approved six medicines on this page for prostate cancer, each for specific patients. Five of them are on at least one Gulf register we checked, so ask your hospital about local supply first. Otherwise the hospital can request a named-patient import. Reserve Meds is a digital health company. We do not diagnose or prescribe.

  • US FDA-approved medicines on this page: Xtandi, Nubeqa, Orgovyx, Akeega, Talzenna and Pluvicto.
  • Gulf registration (checked 17 October 2026): see each medicine below.
  • Legal route: Local supply where listed; otherwise a named-patient import request filed by the treating hospital; cell, gene and radioligand therapies at a qualified center.
  • Price: Quote on request.

What is prostate cancer?

Prostate cancer begins in the cells of the prostate, a gland in the male reproductive system below the bladder. It is one of the most common cancers. It often grows slowly and may not cause serious problems if it does not spread, but some prostate cancers grow quickly and spread.[1]

The chance of prostate cancer rises with age, and it is rare before 50. A family history of prostate cancer raises the risk, and some genetic changes are inherited.[1]

Treatment depends on stage and risk and can include monitoring, surgery, radiation and hormone therapy. For advanced disease, US options include androgen receptor inhibitors, PARP inhibitors for tumors with certain gene changes, and a radioligand therapy for PSMA-positive metastatic disease.[2, 3, 4]

Prostate cancer in the Gulf

A review of the Saudi Cancer Registry found 3,607 prostate cancer cases from 2008 to 2017, with a mean age at diagnosis of 71.1 years, 64.2% poorly differentiated tumors and an overall metastasis rate of 31.4%.[5]

US FDA-approved medicines for prostate cancer

Each medicine below is approved in the US for a specific group of patients. The wording summarizes the current US label. Your specialist decides whether any of them is right for the patient.

  • Xtandi (enzalutamide)
    FDA-approved for castration-resistant prostate cancer, metastatic castration-sensitive prostate cancer, and non-metastatic castration-sensitive prostate cancer with high-risk biochemical recurrence. It is taken by mouth.[2]
    Gulf registers: Saudi Arabia: listed in the SFDA drugs list. Abu Dhabi: has an active code in the Abu Dhabi DoH drug code list. Checked 17 October 2026. UAE federal status, Kuwait, Qatar, Bahrain and Oman: not verified in a public register.[6, 7]
    Country guides: Saudi Arabia, UAE, Egypt, India, Pakistan
  • Nubeqa (darolutamide)
    FDA-approved for adults with non-metastatic castration-resistant prostate cancer and metastatic castration-sensitive prostate cancer, including with docetaxel. It is a tablet.[8]
    Gulf registers: Saudi Arabia: listed in the SFDA drugs list. Abu Dhabi: has an active code in the Abu Dhabi DoH drug code list. Checked 17 October 2026. UAE federal status, Kuwait, Qatar, Bahrain and Oman: not verified in a public register.[6, 7]
  • Orgovyx (relugolix)
    FDA-approved for adults with advanced prostate cancer. It is a tablet that lowers testosterone.[9]
    Gulf registers: Saudi Arabia: not found by brand name in the SFDA drugs list. Abu Dhabi: not found by brand name in the Abu Dhabi DoH drug code list. Checked 17 October 2026. UAE federal status, Kuwait, Qatar, Bahrain and Oman: not verified in a public register.[6, 7]
  • Akeega (niraparib tosylate monohydrate and abiraterone acetate)
    FDA-approved for adults with BRCA-mutated metastatic castration-resistant prostate cancer and BRCA2-mutated metastatic castration-sensitive prostate cancer, with prednisone. It combines niraparib and abiraterone in a tablet.[3]
    Gulf registers: Saudi Arabia: listed in the SFDA drugs list. Abu Dhabi: has an active code in the Abu Dhabi DoH drug code list. Checked 17 October 2026. UAE federal status, Kuwait, Qatar, Bahrain and Oman: not verified in a public register.[6, 7]
    Country guides: Saudi Arabia, UAE, Kuwait, Qatar, Bahrain, Egypt, Jordan, India, Pakistan
  • Talzenna (talazoparib)
    FDA-approved for adults with HRR gene-mutated metastatic castration-resistant prostate cancer, together with enzalutamide. It is a capsule.[10]
    Gulf registers: Saudi Arabia: listed in the SFDA drugs list. Abu Dhabi: has an active code in the Abu Dhabi DoH drug code list. Checked 17 October 2026. UAE federal status, Kuwait, Qatar, Bahrain and Oman: not verified in a public register.[6, 7]
    Country guides: Saudi Arabia, UAE, Kuwait, Qatar, Bahrain, Oman, India
  • Pluvicto (lutetium lu 177 vipivotide tetraxetan)
    FDA-approved for adults with PSMA-positive metastatic prostate cancer in the settings listed in the label. It is a radioligand therapy given by intravenous injection in a nuclear medicine department.[4]
    Given at a qualified treatment center. Gulf registers: Saudi Arabia: listed in the SFDA drugs list. Abu Dhabi: has an active code in the Abu Dhabi DoH drug code list. Checked 17 October 2026. UAE federal status, Kuwait, Qatar, Bahrain and Oman: not verified in a public register.[6, 7]
    Country guides: Saudi Arabia, UAE, Kuwait, Qatar, Bahrain, Oman, Pakistan

How families in the Gulf can access these medicines

If the medicine is listed in your country. Ask your specialist and the hospital pharmacy about local supply first. A listing does not mean every hospital stocks the medicine, and another brand of the same medicine may also be registered, but local supply is usually the fastest route and you may not need us.

If it is not registered. The usual legal route is a named-patient request: the treating hospital, on your specialist's written request, asks the national regulator for permission to import the medicine for one patient, using the US FDA approval as the reference. In Saudi Arabia the SFDA Special Access Program guidance covers these requests; in Bahrain, NHRA Circular 41 of 2020 sets the procedure. Other Gulf countries have their own procedures, which the hospital pharmacy confirms.[11, 12] Once approval is in place, Reserve Meds arranges supply through a US-licensed pharmaceutical wholesale partner to the hospital pharmacy.

For Pluvicto. These treatments are made for each patient or need a specialized procedure, and Pluvicto is radioactive, so treatment happens at a qualified center. For most Gulf families that means a referral from the treating specialist to a center that can give the treatment. A local hospital can only give it if the manufacturer agrees to supply that hospital and the regulator approves. We cannot promise that a manufacturer will agree.

Who does what

  • Your treating specialist decides whether a medicine is right for the patient and writes the letter.
  • The hospital checks local supply, files any import request, and gives the treatment safely.
  • The national regulator decides whether to approve the import of a medicine that is not registered.
  • The manufacturer decides where its medicine can be supplied, especially for cell and gene therapies.
  • Reserve Meds helps organize records, coordinates US supply through our wholesale partner, shipping and updates to your family. We do not give medical advice.

Documents you will usually need

  • A letter from the treating specialist with the diagnosis, past treatments and why the medicine is being considered
  • Reports that confirm the diagnosis, such as laboratory, genetic, imaging or pathology results, translated into English where needed
  • Recent clinic notes and a list of current medicines
  • For a hospital import request: the prescription, the hospital's request form and the written consent of the patient or guardian
  • Proof of the US FDA approval and the US prescribing information (we can supply these)

We give you a written timeline estimate once we see the hospital file. The regulator, the treatment center and the manufacturer set their own timelines.

What treatment costs

Quote on request. Your total cost depends on the medicine, the dose, shipping, import steps and coordination. Your coordination fee is quoted in writing for your case before you commit. No hidden charges.

How Reserve Meds helps

Reserve Meds is a digital health company. Medicines are supplied through a US-licensed pharmaceutical wholesale partner. We help your doctor and hospital prepare the file, arrange US supply and temperature-controlled shipping once approval is in place, and keep your family updated. We coordinate access to FDA-approved medicines only. Investigational medicines are only available through a manufacturer's expanded-access program requested by the treating physician; we can explain that route, but we do not supply them.

Ask us about treatment for prostate cancer

Tell us the medicine, your country and a WhatsApp or phone number. We reply within one business day. On WhatsApp we usually reply the same day.

Include the country code, for example +966 or +971.
Message us on WhatsApp

No account needed. We reply within one business day. Your coordination fee is quoted in writing for your case before you commit. No hidden charges.

Frequently asked questions

Is there an FDA-approved treatment for prostate cancer?

Yes. The medicines on this page have US FDA approval for specific groups of patients: Xtandi, Nubeqa, Orgovyx, Akeega, Talzenna and Pluvicto. The exact conditions are in each US label and are summarized above. Your specialist decides whether any of them fits.

Is Xtandi available in Saudi Arabia or the UAE?

Saudi Arabia: listed in the SFDA drugs list. Abu Dhabi: has an active code in the Abu Dhabi DoH drug code list. Checked 17 October 2026. UAE federal status, Kuwait, Qatar, Bahrain and Oman: not verified in a public register. A listing in Abu Dhabi does not show federal UAE status.

How can a family in the Gulf get Xtandi?

Ask the treating hospital about local supply first. If it is not available, the hospital can file a named-patient import request with the national regulator on your specialist's written request. Once approved, we arrange US supply to the hospital pharmacy.

How much does treatment cost?

Quote on request. Your total cost, including the medicine, shipping, import steps and coordination, is quoted in writing for your case before you commit. No hidden charges.

What does castration-resistant mean?

It means the cancer keeps growing even though testosterone has been lowered with hormone therapy. Several US labels on this page are for this stage.

Can Pluvicto be shipped like other medicines?

Pluvicto is radioactive and is given in a nuclear medicine department, so it cannot be handled like an ordinary import. Treatment usually happens at a center that offers it.

Sources for the last two answers: [2, 10] [4]

Sources

Checked on 17 October 2026. Labels, registers and regulator rules change. Your hospital pharmacy confirms the current position before filing.

  1. MedlinePlus (US National Library of Medicine): Prostate Cancer
  2. DailyMed (US National Library of Medicine): Xtandi (enzalutamide) US prescribing information, version published 3 August 2026
  3. DailyMed (US National Library of Medicine): Akeega (niraparib tosylate monohydrate and abiraterone acetate) US prescribing information, version published 22 December 2025
  4. DailyMed (US National Library of Medicine): Pluvicto (lutetium lu 177 vipivotide tetraxetan) US prescribing information, version published 13 August 2026
  5. Alasker et al. Prostate cancer among Saudis: a registry review. Ann Med Surg (Lond) 2024 (PubMed 38222704)
  6. SFDA: Drugs List, public register (all 9,173 entries checked by brand name on 17 October 2026)
  7. Department of Health Abu Dhabi: drug code list Drugs.xlsx (release 26 September 2026, effective 2 October 2026)
  8. DailyMed (US National Library of Medicine): Nubeqa (darolutamide) US prescribing information, version published 6 October 2026
  9. DailyMed (US National Library of Medicine): Orgovyx (relugolix) US prescribing information, version published 17 November 2025
  10. DailyMed (US National Library of Medicine): Talzenna (talazoparib) US prescribing information, version published 3 June 2026
  11. SFDA: Special Access Program (SAP) guidance, version 1.0
  12. NHRA Bahrain: Circular No. (41) of 2020, procedures for importing non-registered medicines and pharmaceutical products

Related

This page is general health information, not medical advice. It does not replace a consultation with your doctor.

WhatsApp